# Sexual Health Gap: 26 Men's Drugs vs 2 Women's

> Women get 2 FDA-approved sexual health treatments while men have 26, revealing a decades-long research gap.
- Title: Sexual Health Gap: 26 Men's Drugs vs 2 Women's · Woman's World
- Summary: Women get 2 FDA-approved sexual health treatments while men have 26, revealing a decades-long research gap. Women have two FDA-approved treatments for low…
- Keywords: sexual health, fda, addyi, hsdd, clitoris, orgasm gap, women's health, men's health, research gap, sexual dysfunction, Sexual, Health
- Source: Woman's World — https://womansworld.com/wellness/inside-the-outrageous-gap-in-sexual-health-research-for-women
- Author: Lisa Maxbauer
- Published: 2026-10-07T14:00:56+00:00
- Read time: 1 min
- Topics: sexual health, fda, addyi, hsdd, clitoris, orgasm gap, women's health, men's health, research gap, sexual dysfunction
## The Sexual Health Gap
Women get 2 FDA-approved treatments for low desire while men have 26, revealing a decades-long research gap.
## Historical Research Exclusion
Clinical research focused on male subjects for most history, with findings often incorrectly extrapolated to women's bodies.
## NIH Policy Change
The NIH changed its policy in 1993 to include women in clinical testing with the NIH Revitalization Act.
## Women's Health Budget
Women's health research budget was only 10 percent of NIH's total budget, with menopause receiving less than .03 percent.
## Clitoris Research Delay
Scientists mapped the clitoris nerves in 2026, decades after mapping the penis nerves.
## FDA Treatment Imbalance
26 FDA-approved products for men's sexual health versus 1 daily pill for women with hyposexual desire disorder.
## Addyi Approval Timeline
Addyi was approved for premenopausal women in 2015 and postmenopausal women under age 65 in 2025.
## The Orgasm Gap
95 percent of men usually orgasm versus 65 percent of women, creating a 30 percentage point gap.
## Women's Health Advocacy
Women's health champion Cindy Eckert fought to get Addyi approved after Viagra's 1998 approval.
## New Hope for Women
Two FDA-approved treatments offer hope for women, reflecting years of advocacy to close a gender gap in sexual health.
## Key takeaway

Women have two FDA-approved treatments for low desire while men have 26, highlighting a historical gender disparity in sexual health research.